In humans, heterozygous mutations of HNF1B are associated with several diseases such as pancreatic β-cell dysfunction leading to maturity-onset diabetes of the young (MODY5), defective kidney development, disturbed liver function, pancreas atrophy, and malformations of the genital tract [1], [2]. This evidence concerns the gene HNF1B and maturity-onset diabetes of the young.